Paraoxonase 2 Induces a Phenotypic Switch in Macrophage Polarization Favoring an M2 Anti-Inflammatory State

Marie Koren-Gluzer1, Mira Rosenblat1, Tony Hayek2

  • 1The Lipid Research Laboratory, Technion Faculty of Medicine, The Rappaport Family Institute for Research in the Medical Sciences, and Rambam Health Care Campus, 31096 Haifa, Israel.

Insights

Paraoxonase 2 (PON2) influences macrophage inflammatory responses. Studies show PON2 promotes a shift from proinflammatory (M1) to anti-inflammatory (M2) macrophage phenotypes, impacting atherosclerosis development.

Area of Science:

  • Immunology
  • Cardiovascular Biology
  • Molecular Biology

Background:

  • Inflammation is central to atherosclerosis development.
  • Macrophages, with proinflammatory (M1) and anti-inflammatory (M2) phenotypes, are key players in atherogenesis.
  • Paraoxonase 2 (PON2) expression in macrophages is protective against atherosclerosis.

Purpose of the Study:

  • To investigate the direct impact of PON2 on macrophage inflammatory phenotypes.
  • To understand PON2's role in regulating M1 and M2 macrophage polarization.

Main Methods:

  • Ex vivo studies using murine peritoneal macrophages (MPM) from control and PON2-deficient (PON2KO) mice.
  • Macrophage activation using IFNγ, lipopolysaccharide (LPS), and IL-4.
  • Transfection of human PON2 (hPON2) into PON2KO MPM to assess direct effects.
  • Analysis of phagocytosis and reactive oxygen species (ROS) production.

Main Results:

  • PON2KO MPM exhibited an enhanced proinflammatory (M1) phenotype and reduced anti-inflammatory (M2) responses.
  • PON2-null macrophages showed increased phagocytosis and ROS production.
  • hPON2 transfection into PON2KO MPM attenuated M1 activation, enhanced M2 response, and reduced phagocytosis and ROS generation.

Conclusions:

  • PON2 directly influences macrophage polarization.
  • PON2 promotes a switch from M1 to M2 macrophage phenotypes.
  • These findings highlight PON2's atheroprotective role by modulating macrophage inflammatory status.